Fuentes Marcela, Santander Nicolás, Cortés Víctor
Department of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
J Cell Biochem. 2019 Feb;120(2):1550-1559. doi: 10.1002/jcb.27410. Epub 2018 Oct 2.
The actions of insulin on intestinal cholesterol absorption and lipoprotein secretion are not well understood. Herein, we determined the effects of insulin on the levels of cholesterol transporter scavenger receptor, class B, type I (SR-BI), cellular cholesterol uptake, intracellular lipid accumulation, and lipoprotein secretion in a cellular model of human intestinal epithelium.
CaCo-2 cells were cultured to postconfluency in Transwell filters and stimulated with glucose (25 mM) in the presence or absence of insulin (100 nM) at their basolateral surface. SR-BI mRNA and protein levels were quantified by quantitative reverse transcription-PCR and immunoblot, respectively. Polarized localization of SR-BI was determined by cell surface proteins biotinylation and streptavidin precipitation. Activities of PI3K, AKT, mTOR, and SR-BI were pharmacologically antagonized. Cholesterol uptake was assessed by NBD-cholesterol incorporation. Apolipoprotein (apo) B concentration was quantified by ELISA. Subcellular localization of neutral lipids (BODIPY) and SR-BI (immunofluorescence) was determined by confocal microscopy.
In polarized CaCo-2 cells, insulin increased SR-BI at the mRNA and protein levels. SR-BI was exclusively present at apical cell surface, as indicated by biotinylation and confocal microscopy analysis. Glucose did not modify SR-BI abundance or subcellular localization. Effects of insulin on SR-BI levels were abrogated by PI3K, AKT, or mTOR pharmacological antagonism. Cholesterol uptake, neutral lipid abundance, and apo B secretion were increased by insulin in CaCo-2 cells, and these effects were prevented by SR-BI pharmacological antagonism with block lipid transport-1.
insulin promotes cholesterol uptake, intracellular lipid store, and apo B-containing lipoproteins secretion by SR-BI-dependent mechanisms in a model of human intestinal epithelium.
胰岛素对肠道胆固醇吸收和脂蛋白分泌的作用尚未完全明确。在此,我们在人肠上皮细胞模型中确定了胰岛素对胆固醇转运蛋白清道夫受体B类I型(SR-BI)水平、细胞胆固醇摄取、细胞内脂质积累和脂蛋白分泌的影响。
将Caco-2细胞培养至在Transwell滤器中汇合后,在其基底外侧表面存在或不存在胰岛素(100 nM)的情况下用葡萄糖(25 mM)刺激。分别通过定量逆转录PCR和免疫印迹法对SR-BI mRNA和蛋白水平进行定量。通过细胞表面蛋白生物素化和链霉亲和素沉淀确定SR-BI的极化定位。PI3K、AKT、mTOR和SR-BI的活性通过药理学方法进行拮抗。通过NBD-胆固醇掺入评估胆固醇摄取。通过ELISA定量载脂蛋白(apo)B浓度。通过共聚焦显微镜确定中性脂质(BODIPY)和SR-BI(免疫荧光)的亚细胞定位。
在极化的Caco-2细胞中,胰岛素在mRNA和蛋白水平上增加了SR-BI。生物素化和共聚焦显微镜分析表明,SR-BI仅存在于顶端细胞表面。葡萄糖未改变SR-BI的丰度或亚细胞定位。PI3K、AKT或mTOR药理学拮抗可消除胰岛素对SR-BI水平的影响。胰岛素增加了Caco-2细胞中的胆固醇摄取、中性脂质丰度和apo B分泌,而这些作用可通过用阻断脂质转运-1对SR-BI进行药理学拮抗来预防。
在人肠上皮细胞模型中,胰岛素通过依赖SR-BI的机制促进胆固醇摄取、细胞内脂质储存和含apo B脂蛋白的分泌。